|
SURF4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.802700E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.715800E-03 |
| Normal-vs-Stage2 |
3.293600E-02 |
| Normal-vs-Stage3 |
3.97839999999317E-06 |
| Normal-vs-Stage4 |
1.836640E-04 |
| Stage1-vs-Stage2 |
9.403000E-01 |
| Stage1-vs-Stage3 |
3.777500E-02 |
| Stage1-vs-Stage4 |
7.907700E-02 |
| Stage2-vs-Stage3 |
2.419200E-01 |
| Stage2-vs-Stage4 |
2.375400E-01 |
| Stage3-vs-Stage4 |
8.101200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.179500E-04 |
| Normal-vs-AfricanAmerican |
7.527900E-02 |
| Normal-vs-Asian |
4.959900E-03 |
| Caucasian-vs-AfricanAmerican |
4.483200E-01 |
| Caucasian-vs-Asian |
8.144400E-01 |
| AfricanAmerican-vs-Asian |
5.938000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.864820E-03 |
| Normal-vs-Female |
3.845200E-04 |
| Male-vs-Female |
9.292400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.500480E-02 |
| Normal-vs-Age(41-60Yrs) |
4.637300E-04 |
| Normal-vs-Age(61-80Yrs) |
1.82108999999819E-05 |
| Normal-vs-Age(81-100Yrs) |
2.119600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.667640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.253660E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.838400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.588200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.688000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.424200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.513960E-02 |
| Classical-VS-Follicular |
3.336400E-01 |
| Classical-VS-Other |
1.046390E-01 |
| Classical-VS-Normal |
2.522300E-03 |
| Tall-VS-Follicular |
1.116170E-01 |
| Tall-VS-Other |
6.781800E-01 |
| Tall-VS-Normal |
1.60303999999778E-05 |
| Follicular-VS-Other |
3.267800E-01 |
| Follicular-VS-Normal |
1.421630E-03 |
| Other-VS-Normal |
3.958200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.595860E-03 |
| Normal-vs-N1 |
2.34880000005155E-07 |
| N0-vs-N1 |
5.996100E-03 |
|
|
